NICE have updated their quality standard on epilepsies in children, young people and adults. It describes high quality care in priority areas for improvement. This includes new statements on mental health and learning disabilities.
People who have an increased risk for progression to severe COVID-19 will be eligible for Paxlovid if they test positive following our updated final draft guidance. Paxlovid is an antiviral medicine that stops the virus from growing and spreading.
Nice directors look back on a year of 'game-changing' guidance. In this episode of NICE Talks podcast, the directors of NICE’s guidance producing centres discuss key achievements from 2023.
Improving transitions from children’s to adults’ services.
Melanie Carr, technical analyst in our quality standards and indicators team, explains how our updated quality standard on the transition from children’s to adults’ services will benefit young people, their families and carers.
Read Melanie's blog here.
Mon 12 February - 11am-12pm - virtual event: Focusing on what matters most: NICE's new approach to prioritising guidance. Book your free place here.
Join on Monday 12 February, 11am to 12 noon for this free online event. You’ll hear how NICE is:
Mon 19 Feb - 1-2.30pm: A new people and community involvement and engagement strategy for NICE. Book your free place here.
Do you want to help shape how NICE engages and involves people and communities? Join their free webinar to learn more about NICE's draft strategy and consultation. Book your place and find out how you can get involved.
Current consultations include:
See all open consultations here.
NICE currently have vacancies on our urinary tract infection (recurrent): antimicrobial prescribing committee and technology appraisal and highly specialised technologies appeals panel.
Health and care professionals from a wide range of backgrounds work with NICE to produce their recommendations. Your involvement helps to ensure their guidance is useable in practice. Join them and have an active role in producing a guideline or quality standard.
See all committee vacancies here.
NICE's advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all public meetings here.
